Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese (Q31121920)

29 June 2017

title

Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese (English)

1 reference

dexamethasone suppression test

29 June 2017

0 references

0 references

1 reference

1 reference

4

Mark Niven

1 reference

29 June 2017

Caroline M Apovian

3

0 references

author name string

Rosane Ness-Abramof

1

1 reference

29 June 2017

Dan Nabriski

2

1 reference

29 June 2017

Eliahu Weiss

5

1 reference

29 June 2017

Menachem S Shapiro

6

1 reference

29 June 2017

Louis Shenkman

7

1 reference

29 June 2017

publication date

1 December 2002

1 reference

29 June 2017

1 reference

29 June 2017

volume

10

1 reference

29 June 2017

issue

12

1 reference

29 June 2017

page(s)

1217-1221

1 reference

Cushing's syndrome: A review of diagnostic tests

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Incidentalomas. A disease of modern technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Clinical and biochemical evaluation of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome--recommendations for a protocol for biochemistry laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Diagnosis and differential diagnosis of Cushing's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

A RAPID SCREENING TEST FOR CUSHING'S SYNDROME

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Cushing's syndrome: A prospective study of diagnostic methods

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Glucocorticoid action and the clinical features of Cushing's syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Epidemiology of Cushing's syndrome and subclinical disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Adrenal incidentalomas and glucocorticoid autonomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

The overnight dexamethasone test is a worthwhile screening procedure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

The overnight dexamethasone test is the procedure of choice in screening for Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

Overnight dexamethasone suppression test: comparison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2002.166

31 March 2020

Identifiers

DOI

10.1038/OBY.2002.166

1 reference

29 June 2017

1 reference